No Data
No Data
No Data
No Data
No Data
Kiromic BioPharma Files to Withdraw Registration Statement
Seeking AlphaApr 10 17:19 ET
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial
PDF Version Favorable Safety and Tolerability also Observed HOUSTON--(BUSINESS WIRE)--Mar. 19, 2024-- Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports early efficacy res
Kiromic BioPharmaMar 19 00:00 ET
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Yahoo FinanceMar 8 08:35 ET
Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024
Yahoo FinanceMar 5 08:35 ET
Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
PDF Version Third Patient Enrolled in Deltacel-01 Completes Treatment HOUSTON--(BUSINESS WIRE)--Mar. 1, 2024-- Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") announces that Vi
Kiromic BioPharmaMar 1 00:00 ET
Kiromic BioPharma to Present at the OTC Markets' Virtual Life Science Investor Forum on March 7th
PDF Version Live and Archived Fireside Chat Available at VirtualInvestorConferences.com HOUSTON--(BUSINESS WIRE)--Feb. 28, 2024-- Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company"
Kiromic BioPharmaFeb 28 00:00 ET
No Data
No Data